Loading company…
Prana Thoracic develops minimally invasive devices for detecting and treating early-stage lung cancer.
Founded in 2022 and based in Houston, Prana Thoracic develops lung-sparing devices for early intervention on suspicious pulmonary nodules. Its ThoraCore device is a bipolar electrosurgical tool for excising lung tissue during open, thoracoscopic, or transthoracic procedures. In March 2023, it raised USD 10 million in Series A funding led by New World Angels, with Johnson & Johnson Innovation, Texas Medical Center Ventures, and Phase 1 Ventures participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in